[News Brief] WHO Prequalifies First Malaria Treatment for Newborns
The World Health Organization has prequalified Coartem Baby (artemether-lumefantrine), the first malaria treatment specifically developed for newborns and young infants…
The World Health Organization has prequalified Coartem Baby (artemether-lumefantrine), the first malaria treatment specifically developed for newborns and young infants…
Cirrus Therapeutics has expanded into Singapore with a new R&D site and formed a partnership with A*STAR to advance ophthalmic…
ImmunoScape has signed a Memorandum of Understanding with a US-based cancer centre to launch an investigator-initiated clinical trial targeting WT1-positive…
Nanyang Technological University (NTU) Singapore and University Medical Center Utrecht (UMC Utrecht) have formed a collaboration to advance healthcare research,…
Esaote has introduced the MyLab™ E85 GTS, a cart-based ultrasound system for interventional radiology, during the European Congress of Radiology…
The United Laboratories International Holdings Limited and Novo Nordisk A/S announced topline results from a Chinese phase 2 trial of…
OneSource Specialty Pharma has received regulatory approval in Saudi Arabia to commercialise a generic version of Ozempic® (semaglutide) in collaboration…
ImmunityBio has partnered with Biopharma and Cigalah Healthcare to commercialise ANKTIVA® (nogapendekin alfa inbakicept) in Saudi Arabia for bladder and…
Pharmapack Europe has announced the launch of a new Pharmapack Asia event in Singapore, slated for November 2026, offering a…
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Singapore’s Health Sciences Authority (HSA) have introduced a new Regulatory…